Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Clearside Biomedical Inc

CLSD
0,93
0,00 (0,00%)
20 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202413:05GLOBEClearside Biomedical Announces Publication of Critical..
25/11/202413:05GLOBEClearside Biomedical Extends Global Footprint with Numerous..
12/11/202422:10EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEClearside Biomedical Announces Third Quarter 2024 Financial..
07/11/202415:05GLOBEClearside Biomedical Partner Arctic Vision Executes..
06/11/202413:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
04/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202413:05GLOBEClearside Biomedical Appoints Tony Gibney as New Chair of..
31/10/202412:05GLOBEClearside Biomedical to Report Third Quarter 2024 Financial..
22/10/202413:05GLOBEClearside Biomedical’s Positive ODYSSEY Wet AMD Data and..
09/10/202413:55EDGAR2Form 8-K - Current report
09/10/202412:30GLOBEClearside Biomedical Announces Positive Topline Results from..
27/8/202413:05GLOBEClearside Biomedical Announces Completion of Final..
12/8/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:15EDGAR2Form 8-K - Current report
12/8/202422:05GLOBEClearside Biomedical Announces Second Quarter 2024 Financial..
08/8/202413:05GLOBEClearside Biomedical to Participate in the H.C. Wainwright..
01/8/202413:05GLOBEClearside Biomedical to Report Second Quarter 2024 Financial..
29/7/202422:05GLOBEClearside Biomedical’s Partner Arctic Vision Reports..
24/7/202413:55EDGAR2Form 8-K - Current report
22/7/202418:00GLOBEClearside Biomedical Opens Registration for Suprachoroidal..
11/7/202413:05GLOBEClearside Biomedical Appoints Dr. Glenn Yiu to its..
27/6/202413:05GLOBEClearside Biomedical to Host Virtual Key Opinion Leader..
12/6/202413:05GLOBEClearside Biomedical’s Leadership in Suprachoroidal Delivery..
21/5/202413:05GLOBEClearside Biomedical Announces Publication of Consensus..
10/5/202422:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202422:10EDGAR2Form 8-K - Current report
09/5/202422:05GLOBEClearside Biomedical Announces First Quarter 2024 Financial..
08/5/202422:15GLOBEClearside Biomedical to Participate in Fireside Chat at the..
30/4/202413:05GLOBEClearside Biomedical to Report First Quarter 2024 Financial..
16/4/202413:05GLOBEClearside Biomedical Appoints Seasoned Biotechnology..
02/4/202413:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
18/3/202412:05GLOBEClearside Biomedical Appoints Victor Chong, M.D., MBA as..
12/3/202421:05GLOBEClearside Biomedical Announces Fourth Quarter and Full Year..
29/2/202413:05GLOBEClearside Biomedical to Report Fourth Quarter and Full Year..
08/2/202423:05EDGAR2Form 8-K - Current report
08/2/202422:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/2/202414:00GLOBEClearside Biomedical Announces Pricing of $15 Million..
01/2/202422:01EDGAR2Form 8-K - Current report
20/1/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202421:04EDGAR2Form 144 - Report of proposed sale of securities
28/12/202322:10EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 0,93

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network